AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of -$0.34–$0.28 for the period, compared to the consensus EPS estimate of -$0.02. The company issued revenue guidance of $328.00 million-$333.00 million, compared to the consensus revenue estimate of $353.62 million. Analyst Ratings Changes A number […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Separately, Raymond James lowered shares of AngioDynamics from a “strong-buy” rating to an “outperform” rating and lowered their target price for the stock from $14.00 to $13.00 […]
AngioDynamics (NASDAQ:ANGO) Updates FY 2024 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AngioDynamics (NASDAQ:ANGO – Get Free Report) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02, MarketWatch Earnings reports. The business had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $90.73 million. AngioDynamics had a negative return on […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of ($0.34)-($0.28) for the period, compared to the consensus earnings per share estimate of ($0.03). The company issued revenue guidance of $328-333 million, compared to the consensus revenue estimate of $353.75 million. Analyst Ratings Changes […]